首页|基于生物信息学分析DNASE1L3在肝细胞癌中表达及对预后的影响

基于生物信息学分析DNASE1L3在肝细胞癌中表达及对预后的影响

扫码查看
目的:探究DNASE1L3在肝细胞癌中的表达情况以及对患者预后的影响,并通过生物信息学方法探索其潜在的影响途径.方法:基于TCGA、GSE14520和HPA数据库肝细胞癌数据分析DNASE1L3在正常和肿瘤组织中的表达差异.通过单因素及多因素COX回归分析及Kaplan-Meier生存分析探究DNASE1L3对肝细胞癌预后影响.基于GSE6764数据分析DNASE1L3在肿瘤不同进展时期的表达变化.使用ESTIMATE算法分析DNASE1L3与免疫和基质细胞浸润及肿瘤纯度的关系.使用Limma包对GSVA富集结果进行差异分析,并通过GeneMINIA在线工具挖掘DNASE1L3共表达基因.结果:DNASE1L3在肿瘤组织中表达减低,并且与患者预后不良相关.DNASE1L3在较大的肿瘤、较高的甲胎蛋白(AFP)水平和较晚期的肿瘤组织中的表达水平减低,并且随着肿瘤进展逐步减低.DNASE1L3低表达肿瘤组织中的免疫基质细胞丰度较低,而肿瘤纯度较高,数种免疫检查点基因表达也会增高.富集差异分析及共表达基因富集发现DNASE1L3主要涉及肝细胞癌的DNA损伤修复、细胞周期、脂肪酸代谢、糖酵解等过程,并涉及了免疫细胞浸润的调节过程.结论:DNASE1L3在肝细胞癌组织中低表达,影响肿瘤进展和肿瘤免疫过程,是一种有前途的预后分子标志物及治疗靶点,需要进一步地探索和研究.
DNASE1L3 expression and its impact on prognosis in hepatocellular carcinoma based on bioinformatics
Objective:To analyze the expression of DNASE1L3 in hepatocellular carcinoma and its impact on patient prognosis,and explore the potential pathways through bioinformatics analysis.Methods:Based on TCGA,GSE14520,and HPA databases,the differential expression of DNASE1L3 be-tween normal and tumor tissues in hepatocellular carcinoma was analyzed.Univariate and multivariate COX regression analysis and Kaplan-Meier survival analysis were conducted to explore the impact of DNASE1L3 on the prognosis of hepatocellular carcinoma.The expression changes of DNASE1L3 in different stages of tumor progression were analyzed based on GSE6764 data.The relationship be-tween DNASE1L3 and immune cell infiltration,stromal cell infiltration,and tumor purity was ana-lyzed using the ESTIMATE algorithm.The enriched results of GSVA were subjected to differential analysis using the Limmapackage,and the co-expressed genes of DNASE1L3 were explored through the GeneMINIA online tool.Results:DNASE1L3 was downregulated in tumor tissues,which was associated with poor prognosis in patients.The expression of DNASE1L3 was decreased in larger tu-mors,higher alpha fetoprotein(AFP)levels,and more advanced stages of tumor tissue,and it further reduced tumor progression.Low expression of DNASE 1L3 may indicate lower immune stromal abun-dance and higher tumor purity in the tumor microenvironment,and it was associated with increased ex-pression of some immune checkpoint genes.Enrichment differential analysis and co-expression gene enrichment suggested that DNASE1L3 was mainly involved in DNA damage repair,cell cycle,fatty acid metabolism,and glycolysis,and it may be involved in regulating immune cell infiltration in hepa-tocellular carcinoma.Conclusion:DNASE1L3 was downregulated in hepatocellular carcinoma tis-sues and was involved in the tumor progression and tumor immune processes.It is a promising prog-nostic molecular biomarker and therapeutic target that requires further exploration and investigation.

DNASE1L3Hepatocellular CarcinomaBioinformatics AnalysisTumor Immunity

符赞美、蔡伟国、龙清云、卢伟

展开 >

武汉大学中南医院介入诊疗中心 湖北 武汉 430071

DNASE1L3 肝细胞癌 生物信息学分析 肿瘤免疫

2024

武汉大学学报(医学版)
武汉大学

武汉大学学报(医学版)

CSTPCD
影响因子:0.959
ISSN:1671-8852
年,卷(期):2024.45(8)
  • 4